title: Role of prostaglandins in lipopolysaccharide effects on K+-induced contractions in rabbit small intestine.
abstract: OBJECTIVE
  The mediators of the pathophysiologcal symptoms of septic shock are not completely understood. The aim of this work was to investigate the effect of lipopolysaccharide (LPS) on the K+-induced response of longitudinal segments of rabbit small intestine in vitro and the possible role of prostaglandins.
  
  
  RESULTS
  Rabbits were treated with intravenously injected LPS. After 90 min animals were killed and intestinal segments were mounted in an organ bath. Lipopolysaccharide (0.2 microg kg-1) inhibited K+-induced contractions (60 mm) by 68% in duodenum, 58% in jejunum and 52% in ileum. Indomethacin antagonized LPS actions when injected 15 min before LPS. PGE2 reduced K+-induced contractions, imitating LPS effects. In contrast, contractions induced by K+ increased when intestinal segments were incubated in vitro with LPS for 90 min. The LPS (0.3 microg mL-1) increased K+-induced contractions (60 mm) by 46% in duodenum, 63% in jejunum and 85% in ileum. The LPS effect was antagonized by indomethacin at 10-6 m in duodenum and jejunum and at 10-8 m in ileum. PGE2 evoked dose-dependent contractions when added to the bath in duodenum, jejunum and ileum.
  
  
  CONCLUSIONS
  These results suggest that effect of LPS on K+-induced contractions in the rabbit small bowel may be mediated by prostaglandin E2.
authors: Departamento de Farmacología y Fisiología (Fisiología), Facultad de Veterinaria, Universidad de Zaragoza, Zaragoza, Spain.
authors: E
authors: E
authors: Rebollar
authors: E
authors: E
authors: Guerrero-Lindner
authors: M P
authors: MP
authors: Arruebo
authors: M A
authors: MA
authors: Plaza
authors: M D
authors: MD
authors: Murillo
mesh_terms: D000818:Animals; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D015232:Dinoprostone / Q000494:pharmacology / Q000502:physiology*; D004386:Duodenum / Q000187:drug effects / Q000502:physiology; D007082:Ileum / Q000187:drug effects / Q000502:physiology; D007213:Indomethacin / Q000494:pharmacology; D007275:Injections, Intravenous; D007421:Intestine, Small / Q000187:drug effects / Q000502:physiology*; D007583:Jejunum / Q000187:drug effects / Q000502:physiology; D008070:Lipopolysaccharides / Q000008:administration & dosage*; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects / Q000502:physiology*; D009130:Muscle, Smooth / Q000187:drug effects / Q000502:physiology; D011188:Potassium / Q000502:physiology*; D011817:Rabbits
chemical_list: D016861:Cyclooxygenase Inhibitors; D008070:Lipopolysaccharides; D015232:Dinoprostone; D011188:Potassium; D007213:Indomethacin